Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001628280-24-047921
Filing Date
2024-11-14
Accepted
2024-11-14 16:27:52
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 gribios-3.htm S-3 277349
2 EX-FILING FEES exhibit107-sx3november2024.htm EX-FILING FEES 27024
3 EX-5.1 exhibit51-sx3november2024.htm EX-5.1 16362
4 EX-23.1 exhibit231-sx3november2024.htm EX-23.1 2131
5 gribiologoa.jpg GRAPHIC 31417
6 mintzlogoa.jpg GRAPHIC 12257
  Complete submission text file 0001628280-24-047921.txt   384326
Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 208 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 208 LA JOLLA CA 92037 (619) 400-1171
GRI Bio, Inc. (Filer) CIK: 0001824293 (see all company filings)

EIN.: 824369909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-283234 | Film No.: 241463010
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)